Keyphrases
Indonesia
80%
Brain Tumor
66%
Neuro-oncology
64%
Cancer Pain
57%
Brain Tumor Patients
53%
Cancer Burden
37%
Type 2 Diabetes Mellitus (T2DM)
37%
Developing Countries
37%
Cancer Epidemiology
32%
Narrative Literature Review
32%
Mutant p53
32%
Intracranial Meningioma
32%
Leprous Neuropathy
32%
Adipose-derived Stromal Vascular Fraction
32%
Endometriosis-associated Pain
32%
Ankyrin
32%
Chronic Headache
32%
Multi-arm
32%
Cancer Registry Data
32%
Stromal Vascular Fraction
32%
Early Predictors
32%
Neuro-ophthalmic Manifestation
32%
Cortical Brain
32%
Scale Assessment
32%
Neuropathic Pain
32%
Referral Hospital
32%
Insulin
32%
Underutilization
32%
Hemoglobin A1c (HbA1c)
32%
Type 2 Diabetic Patients
32%
Metformin
32%
Pada
32%
Hospital-based Cancer Registry
32%
Antineoplastic Agents
32%
Anticoagulants
32%
Methylation Status
32%
Oncology Patients
32%
Meningioma Recurrence
32%
Palliative Care
32%
Adult Brain Tumors
32%
Neuropathic Cancer Pain
32%
Meningioma
32%
Karnofsky Performance Status
32%
Venous Thromboembolism Prophylaxis
32%
Jakarta
32%
Glioma
32%
DNA Methylation (DNAm)
32%
Neurological Examination
32%
Neuropsychiatric Events
32%
Clopidogrel Response
32%
Medicine and Dentistry
Brain Tumor
78%
Brain Metastasis
77%
Malignant Neoplasm
69%
Systematic Review
64%
Neuro-Oncology
64%
Symptomatic Treatment
42%
Methylation
36%
Quality of Life
35%
Ankyrin
32%
Adipose Tissue
32%
Cancer Pain
32%
Neuropathy
32%
Descriptive Epidemiology
32%
Patient Referral
32%
Receptor
32%
Whole Brain Radiotherapy
32%
Glycon
32%
Anticarcinogen
32%
Cancer Registry
32%
Ganglioglioma
32%
Karnofsky Performance Status
32%
Cancer Epidemiology
32%
Endometriosis
32%
Epileptic Seizure
23%
Headache
23%
Neoplasm
23%
Symptom
18%
Clinical Trial
17%
Sensation
16%
Mycobacteria
16%
DNA Methylation
14%
Cancer Pain Management
13%
Weakness
12%
Prevalence
12%
Disease
12%
Radiation Therapy
12%
Nociception
11%
Cohort Effect
10%
Intracranial Tumor
10%
Temozolomide
9%
Overall Survival
9%
Central Nervous System
9%
Progression Free Survival
9%
Central Nervous System Tumor
8%
Progenitor Cell
8%
Mononuclear Cell
8%
Liposuction
8%
Medicine
8%
Peripheral Neuropathy
8%
Flow Cytometry
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Brain Metastasis
96%
Cancer Pain
64%
Brain Tumor
64%
Clinical Trial
44%
Intracranial Tumor
38%
Non Insulin Dependent Diabetes Mellitus
36%
Cancer Epidemiology
32%
Hemoglobin A1c
32%
Protein P53
32%
Meningioma
32%
Recurrent Disease
32%
Epileptic Absence
32%
Ankyrin
32%
Receptor
32%
Metformin
32%
Anticarcinogen
32%
Endometriosis
32%
Venous Thromboembolism
32%
Cancer Registry
32%
Anticoagulant Agent
32%
Systemic Lupus Erythematosus
32%
Prevalence
26%
Disease
23%
Headache
23%
Side Effect
21%
Cohort Study
18%
Observational Study
18%
Recurrence Risk
16%
Progesterone Receptor
16%
Neuropathic Pain
16%
Cognitive Defect
16%
Comorbidity
16%
Randomized Clinical Trial
16%
Neoplasm
16%
Weakness
12%
Vasculotropin
10%
Temozolomide
9%
Overall Survival
9%
Acetylsalicylic Acid
9%
Progression Free Survival
9%
Heparin
9%
Cross-Sectional Study
6%
Eye Movement Disorder
6%
Uterine Cervix Cancer
6%
Cancer Incidence
6%
Symptom
6%
Vasculotropin Receptor
5%
Brain Hernia
5%
Primary Tumor
5%
